Chemical Compound

batimastat

CAS Registry Number 130370-60-4
Back to search Request a Quote
batimastat chemical structure
Primary Record

batimastat

In stock
7,412 g
Purity
99.4 %
CAS
130370-60-4

Compound Identifiers & Properties

CAS
130370-60-4
PubChem CID
5362422
SMILES
CC(C)C[C@H]([C@H](CSC1=CC=CS1)C(=O)NO)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)NC
Canonical SMILES
CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSc1cccs1)C(=O)NO

Names & Synonyms

  • batimastat
  • 130370-60-4
  • batimastatum
  • BB-94
  • Batimastat (BB-94)
  • BB94
  • BB94 cpd
  • Batimastat (MMP Inhibitor)
  • Batimastat(BB-94)
  • AC1NSFYO
  • 1rm8
  • Batimastat(BB-94)?
  • BATIMASTAT [MI]
  • BB 94
  • BATIMASTAT [INN]
  • Batimastat (USAN/INN)
  • RefChem:561113
  • BATIMASTAT [USAN]
  • C23H31N3O4S2
  • BATIMASTAT; BB94
  • D0P8YC
  • Batimastat [USAN:BAN:INN]
  • Batimastat [USAN:INN:BAN]
  • UNII-BK349F52C9
  • BATIMASTAT [MART.]
  • SCHEMBL4332
  • CHEMBL279786
  • BK349F52C9
  • MLS006010631
  • MLS006011226
  • DTXSID20156497
  • MFCD00866533
  • GTPL5145
  • orb1301154
  • Batimastat, >=98% (HPLC)
  • DTXCID2078988
  • CTK8E8474
  • ISV-120
  • ISV-615
  • 2j83
  • CHEBI:195398
  • BB-99
  • GLXC-07095
  • BB94, BB-94
  • EX-A1671
  • ZINC3789788
  • 2251AH
  • BDBM50063918
  • MSK168032
  • s7155
  • 4-Bromo-2-(piperidin-4-yl)thiazole
  • AKOS024457355
  • C23-H31-N3-O4-S2
  • CCG-269520
  • CID5362422
  • CS-1655
  • DB03880
  • QC-8335
  • Batimastat - CAS 130370-60-4
  • CID:5362422
  • KS-000001A9
  • NCGC00346877-01
  • AC-33099
  • AN-32348
  • AS-75198
  • BB162029
  • DA-50944
  • HY-13564
  • LS-45637
  • RS-47112
  • SID:53789458
  • SMR002530309
  • 4-[tert-butyl(diphenyl)silyl]oxybutan-1-ol
  • AB0097216
  • Butanediamide, N4-hydroxy-N1-[(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]-, (2R,3S)-
  • J535.345I
  • RT-011417
  • A2577
  • NS00069199
  • A11441
  • A12985
  • D03061
  • (2S,3R)-N-hydroxy-N'-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-3-(2-methylpropyl)-2-(thiophen-2-ylsulfanylmethyl)butanediamide
  • (2S,3R)-N1-hydroxy-3-isobutyl-N4-((S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl)-2-((thiophen-2-ylthio)methyl)succinamide
  • 370B604
  • A888758
  • C080985
  • 3-(5-methyl-1,2-oxazol-3-yl)-3-oxopropanenitrile
  • Butanediamide, N4-hydroxy-N1-(2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl)-2-(2-methylpropyl)-3-((2-thienylthio)methyl)-, (2R-(1(S*),2R*,3S*))-
  • BRD-K82818427-001-01-4
  • BRD-K82818427-001-02-2
  • BRD-K82818427-001-04-8
  • Q15303190
  • 4-(N-HYDROXYAMINO)-2R-ISOBUTYL-2S-(2-THIENYLTHIOMETHYL)SUCCINYL-L-PHENYLALANINE-N-METHYLAMIDE
  • (4-(N-hydroxyamino)-2-isobutyl-3-(thiophen-2-ylthiomethyl)succinyl)phenylalanine-N-methylamide
  • B2693-082981
  • (2R)-N-[(1S)-1-benzyl-2-(methylamino)-2-oxo-ethyl]-2-[(1S)-2-(hydroxyamino)-2-oxo-1-(2-thienylsulfanylmethyl)ethyl]-4-methyl-pentanamide
  • (2S,3R)-5-Methyl-3-(((alphaS)-alpha-(methylcarbamoyl)phenethyl)carbamoyl)-2-((2-thienylthio)methyl)hexanohydroxamic acid
  • (2R,3S)-N'-hydroxy-N-[(1S)-1-(methylcarbamoyl)-2-phenylethyl]-2-(2-methylpropyl)-3-[(thiophen-2-ylsulfanyl)methyl]butanediamide
  • (2R,3S)-N-hydroxy-N'-[(1S)-1-(methylcarbamoyl)-2-phenylethyl]-2-(2-methylpropyl)-3-[(thiophen-2-ylsulfanyl)methyl]butanediamide
  • (2r,3s)-n4-hydroxy-n1-[(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]butanediamide
  • (2S,3R)-N-hydroxy-N'-[(2S)-1-methylamino-1-oxo-3-phenylpropan-2-yl]-3-(2-methylpropyl)-2-(thiophen-2-ylsulfanylmethyl)butanediamide
  • BAT
  • Butanediamide, N(sup 4)-hydroxy-N(sup 1)-(2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl)-2-(2-methylpropyl)-3-((2-thienylthio)methyl)-, (2R-(1(S*),2R*,3S*))-
  • (2R,3S)-N'-hydroxy-N-((1S)-1-(methylcarbamoyl)-2-phenylethyl)-2-(2-methylpropyl)-3-((thiophen-2-ylsulfanyl)methyl)butanediamide
  • (2R,3S)-N(4)-Hydroxy-N(1)-((1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl)-2-(2-methylpropyl)-3-((2-thienylthio)methyl)butanediamide
  • (2R,3S)-N(4)-hydroxy-N(1)-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-2-(2-methylpropyl)-3-[(thiophen-2-ylsulfanyl)methyl]butanediamide
  • (2R,3S)-N*4*-Hydroxy-2-isobutyl-N*1*-((S)-1-methylcarbamoyl-2-phenyl-ethyl)-3-(thiophen-2-ylsulfanylmethyl)-succinamide
  • (2R,3S)-N-[(S)-1-Benzyl-2-(methylamino)-2-oxoethyl]-N -hydroxy-2-isobutyl-3-[[(thiophen-2-yl)thio]methyl]butanediamide
  • (2R,3S)-N-hydroxy-N'-((1S)-1-(methylcarbamoyl)-2-phenylethyl)-2-(2-methylpropyl)-3-((thiophen-2-ylsulfanyl)methyl)butanediamide
  • (2R,3S)-N~1~-[(1S)-1-benzyl-2-(methylamino)-2-oxoethyl]-N~4~-hydroxy-2-(2-methylpropyl)-3-[(thiophen-2-ylsulfanyl)methyl]butanediamide
  • (2R,3S)-N~4~-Hydroxy-N~1~-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-2-(2-methylpropyl)-3-{[(thiophen-2-yl)sulfanyl]methyl}butanediamide
  • (2R,3S)-N4-Hydroxy-N1-[(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]-butanediamide; [2R-[1(S*),2R*,3S*]]-N4-hydroxy-N1-[2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]-butanediamide; (2S,3R)-5-Methyl-3-[[(?S)-?-(methylcarbamoyl)phenethyl]carbamoyl]-2-[(2-thienylthio)methyl]hexanohydroxamic Acid; BB 94;
  • (4-(N-Hydroxyamino)-2R-isobutyl-3S-(2-thienylthiomethyl)-succinyl)-L-phenylalanine-N-methylamide
  • (4-(N-Hydroxyamino)-2R-isobutyl-3S-(thiophen-2-ylthiomethyl)-succinyl)-L-phenylalanine-N-methylamide
  • 130371-64-1
  • 130372-07-5
  • 4-Methyl-2-[1-methyl-2-(thiophen-2-ylsulfanyl)-ethyl]-pentanoic acid (1-methylcarbamoyl-2-phenyl-ethyl)-amide
  • DSX
  • N*4*-Hydroxy-2-isobutyl-N*1*-(1-methylcarbamoyl-2-phenyl-ethyl)-3-(thiophen-2-ylsulfanylmethyl)-succinamide